Life Sciences, March 21, 2008

Hemispherx getting closer to satisfying application issues

Philadelphia Business Journal - by John George

Hemispherx Biopharma Inc. said it is continuing to make progress on its new drug application (NDA) for Ampligen, the Philadelphia company's experimental treatment for chronic fatigue syndrome.

...

bron:

http://www.bizjournals.com/philadelphia/stories/2008/03/24/newscolumn1.html

Voor eerder berichtgeving over de goedkeuringsprocedure voor Ampligen:

klik hier, hier, hier en hier.